会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • 6-substituted-2-carbaminidoyl-pen-2-em-3-carboxylic acids
    • 6-取代-2-氨基甲酰基 - 二氧戊环-3-羧酸
    • US4748162A
    • 1988-05-31
    • US605338
    • 1984-04-30
    • William J. LeanzaBurton G. ChristensenFrank P. DiNinnoRonald W. Ratcliffe
    • William J. LeanzaBurton G. ChristensenFrank P. DiNinnoRonald W. Ratcliffe
    • C07D499/88C07D499/00A61K31/425
    • C07D499/88
    • Disclosed are 6-substituted-2-carbamimidoyl-pen-2-em-3-carboxylic acids (I) having the representative structure: ##STR1## wherein R.sup.6, and R.sup.7 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, alkoxyl, halo, OH, COOH, alkenyl, aryl and aralkyl; A is a direct, single bond connecting the indicated S and C atoms, or A is a cyclic or acyclic connecting group selected, inter alia, from alkyl, cycloalkyl, aryl, heteroaryl, heteroalkyl; R.sup.1 and R.sup.2, which define the carbamimidoyl function, are, inter alia, independently selected from hydrogen, alkyl, aryl; additionally, said carbamimidoyl is characterized by cyclic structures achieved by the joinder of the two nitrogen atoms via their substituents and by their joinder to connecting group A; additionally, "carbamimidiums" are disclosed by quarternization of one of the nitrogen atoms of said carbamimidoyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    • 公开了具有以下代表性结构的6-取代-2-氨基甲脒基 - 二-2-碳-3-羧酸(I):其中R 6和R 7尤其独立地选自氢 烷基,烷氧基,卤素,OH,COOH,烯基,芳基和芳烷基; A是连接指示的S和C原子的直接的单键,或A是特别是选自烷基,环烷基,芳基,杂芳基,杂烷基的环状或无环连接基团; 定义氨基甲酰基官能团的R 1和R 2尤其独立地选自氢,烷基,芳基; 另外,所述的氨基甲脒基的特征在于通过两个氮原子通过它们的取代基并通过它们与连接基团A的连接而实现的环状结构; 此外,“氨基甲酰胺”是通过季铵化所述氨甲脒基的氮原子而公开的。 这些化合物及其药学上可接受的盐,酯和酰胺衍生物可用作抗生素。 还公开了制备这些化合物的方法; 包含这些化合物的药物组合物; 和治疗方法,包括当指出抗生素效应时施用这些化合物和组合物。
    • 12. 发明授权
    • Substituted N-methylene derivatives of thienamycin
    • 噻吩霉素的取代的N-亚甲基衍生物
    • US4335043A
    • 1982-06-15
    • US84013
    • 1979-10-11
    • Burton G. ChristensenWilliam J. LeanzaKenneth J. Wildonger
    • Burton G. ChristensenWilliam J. LeanzaKenneth J. Wildonger
    • C07D205/08C07F7/10C07D487/04A61K31/40
    • C07F7/10C07D205/08
    • Disclosed are substituted N-methylene derivatives of thienamycin which may be represented by the following structural formula: ##STR1## wherein X and Y are selected from the group consisting of hydrogen, R, OR, SR, and NR.sup.1 R.sup.2 wherein, inter alia, R is substituted or unsubstituted: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl, and heterocyclylalkyl; R.sup.1 and R.sup.2 are hydrogen or R. Such compounds and their pharmaceutically acceptable salt, ether, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    • 公开了噻吩霉素的取代的N-亚甲基衍生物,其可以由以下结构式表示:其中X和Y选自氢,R,OR,SR和NR 1 R 2,其中除了其中R是 取代或未取代的:烷基,烯基,炔基,环烷基,环烷基烷基,芳基,芳烷基,杂芳基,杂芳烷基,杂环基和杂环基烷基; R1和R2是氢或R.这些化合物及其药学上可接受的盐,醚,酯和酰胺衍生物可用作抗生素。 还公开了制备这些化合物的方法; 包含这些化合物的药物组合物; 和治疗方法,包括当指出抗生素效应时施用这些化合物和组合物。